Ian M. Thompson | OMICS International
ISSN: 2161-0711

Journal of Community Medicine & Health Education
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ian M. Thompson

Ian M. Thompson Cancer Therapy and Research Center at the University of Texas Health Science Center 7979 Wurzbach Road, San Antonio TX 78229, USA E-mail: [email protected]


Ian M. Thompson Jr., M.D., is the director of the Cancer Therapy & Research Center and a urologic oncologist who specializes in prevention, early detection, and treatment of prostate and other urologic cancers, including cancers of the kidney, bladder and testis. He serves as a trustee of the American Board of Urology, chairman of the Early Detection Research Network of the National Cancer Institute, and chair of the Genitourinary Cancer Committee of the Southwest Oncology Group, one of the largest cancer treatment trials organizations in the world. He was principal investigator of the Prostate Cancer Prevention Trial, an 18,882-subject study published in 2003 that demonstrated that finasteride can reduce the risk of prostate cancer. In 2004, he and his colleagues published a major discovery, finding that cancers, including aggressive prostate cancers, can be present at lower levels of prostate-specific antigen. He continues to oversee multiple major studies in the United States and abroad with the goal of preventing, detecting or curing prostate cancer.
Research Interest
Cancer Therapy

Global Speakers in the subject

Global Experts in the subject

Relevant Topics